HTG Announces New Patent for Its Technology Issued in Japan – Patent covers nuclease protection methods for detection of nucleotide variants  Continue reading→

Biotech Experienced Directors Further Strengthen the Company LeadershipContinue reading→

Your immune system never sleeps. Every moment of the day, immune cells monitor your body for disease, calling for backup when they detect a threat. It’s a system that works elegantly — most of the time. It’s not foolproof; if it were, we would never get cancer in the first place. 

Continue reading→

Revolutionary Program is Meant to Accelerate Commercialization in Cardiovascular Therapeutics, Bringing New Treatments to Patients Faster and at a Reduced CostContinue reading→

Clinical Microbiome Services Center enhances TGen’s genomic analyses Continue reading→

Now in its fourth year, this area in the BIO Exhibition provides an exciting and interactive experience where investors provide live feedback and judge 6 minute pitches presented by start-up biotech companies.Continue reading→

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America’s Seed Fund, are one of the largest sources of early-stage capital for technology commercialization in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization.Continue reading→